Huntington National Bank’s Kite Pharma, Inc. KITE Stock Holding History

Huntington National Bank’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-130	Closed	-$23K	–	1745
2017 Q3	$23K	Buy	+130	New	+$18.1K	﹤0.01%	1191
2016 Q4	–	Sell	-3	Closed	–	–	1579
2016 Q3	$0	Sell	3 -185	-98%	-$10.3K	﹤0.01%	1630
2016 Q2	$9K	Sell	188 -144	-43%	-$7.08K	﹤0.01%	1263
2016 Q1	$19K	Buy	332 +147	+79%	+$7.12K	﹤0.01%	1375
2015 Q4	$11K	Sell	185 -106	-36%	-$7.46K	﹤0.01%	1354
2015 Q3	$16K	Sell	291 -387	-57%	-$24.3K	﹤0.01%	1338
2015 Q2	$41K	Buy	678 +346	+104%	+$19.7K	﹤0.01%	1168
2015 Q1	$19K	Buy	332 +40	+14%	+$2.68K	﹤0.01%	1380
2014 Q4	$17K	Buy	+292	New	+$12.3K	﹤0.01%	1385

Huntington National Bank's KITE Position: Q4 2017 in Review

Huntington National Bank sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 130 shares — an estimated $23K sold.

Huntington National Bank first reported a position in KITE in Q4 2014 and held it in 9 quarters. The position peaked at $41K in Q2 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Huntington National Bank reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Huntington National Bank sold 130 Kite Pharma, Inc. shares in Q4 2017, an estimated $23K.
Huntington National Bank first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 9 quarters.
Huntington National Bank's Kite Pharma, Inc. position peaked at $41K in Q2 2015.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Huntington National Bank's 13F filing for Q4 2017, filed 2 Feb 2018.